FOLH1 and prostate carcinoma: A number of FDA-approved AI applications in prostate cancer imaging, detection, and classification implemented in clinical practice include ProstatID (Version 2.0), Quantib Prostate (Version 3.0), and PROView (Version 1.0) using MRI images and aPROMISE (Version 1.0) using PSMA PET/CT images [10].